A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib

This report expands the list of gene fusions in IMTs and highlights a new target for treatment.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research